3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Treatment of Venous Thromboembolism in Cancer Patients
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Interventions
fludarabine phosphate
17
Peripheral Blood Stem Cell Transplantation
14
Cyclophosphamide
14
Busulfan
11
Whole-Body Irradiation
10
Tacrolimus
8
Mycophenolic Acid
8
Melphalan
7
Cyclosporine
7
Methotrexate
6
Antilymphocyte Serum
6
Filgrastim
5
Etoposide
5
fludarabine
4
Flow Cytometry
3
Cytarabine
3
Transplantation
2
Thiotepa
2
Stem Cell Transplantation
2
Radiotherapy
2
Polymerase Chain Reaction
2
Methylprednisolone
2
Cytogenetic Analysis
2
Cyclosporins
2
Cord Blood Stem Cell Transplantation
2
Biopsy
2
Aspirin
2
Alemtuzumab
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
tipifarnib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycythemia Vera
×
N(4)-oleylcytosine arabinoside
×
Classical hematology
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled